Back to Search
PAUL HARRIGAN, PH.D.
PH.D.
Counseling Psychologist
NPI: 1407089915Individual
Specialties, Licenses & Credentials
Counseling PsychologistPrimary
Psychologist — Counseling
Code: 103TC1900X
018266(NY)
Research & Publications (20)
Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing.
PMID 19424056·AIDS·2009
8-other
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.
PMID 19406887·BMJ·2009
8-other
HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers.
PMID 19153230·J Virol·2009
8-other
Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulation.
PMID 19179294·J Clin Pharmacol·2009
3-trial
Association between HIV-1 RNA level and CD4 cell count among untreated HIV-infected individuals.
PMID 19218172·Am J Public Health·2009
8-other
Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy.
PMID 18498238·J Infect Dis·2008
8-other
CD4-dependent characteristics of coreceptor use and HIV type 1 V3 sequence in a large population of therapy-naive individuals.
PMID 18240966·AIDS Res Hum Retroviruses·2008
8-other
Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency.
PMID 19005273·AIDS·2008
4-observational
Bayesian network analyses of resistance pathways against efavirenz and nevirapine.
PMID 18832874·AIDS·2008
4-observational
Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants.
PMID 18684095·J Infect Dis·2008
8-other
Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3'-azido-3'-deoxythymidine through both RNase H-dependent and -independent mechanisms.
PMID 18547911·J Biol Chem·2008
8-other
Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
PMID 18181733·Clin Infect Dis·2008
5-case
Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.
PMID 18301076·AIDS·2008
8-other
The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes.
PMID 18845950·J Acquir Immune Defic Syndr·2008
8-other
Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data.
PMID 18360290·J Acquir Immune Defic Syndr·2008
8-other
Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
PMID 18580606·AIDS·2008
8-other
Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag.
PMID 19023406·PLoS Comput Biol·2008
8-other
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
PMID 18498241·J Infect Dis·2008
8-other
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.
PMID 18052601·PLoS Med·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 884 BRIGHTON RD
TONAWANDA, NY 14150 - Phone
- (716) 836-9460
Quick Facts
- NPI
- 1407089915
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile